Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
August 15 2014 - 3:54PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 000-49839
Idenix
Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
320 Bent Street
Cambridge, Massachusetts 02141
(617) 995-9800
(Address,
including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock,
$0.001 par value
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an
X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1)
|
|
x
|
Rule 12g-4(a)(2)
|
|
¨
|
Rule 12h-3(b)(1)(i)
|
|
x
|
Rule 12h-3(b)(1)(ii)
|
|
¨
|
Rule 15d-6
|
|
¨
|
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Idenix Pharmaceuticals, Inc. has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
Date: August 15, 2014
|
|
|
|
By:
|
|
/s/ Katie Fedosz
|
|
|
|
|
Name:
|
|
Katie Fedosz
|
|
|
|
|
Title:
|
|
Assistant Secretary
|
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Apr 2023 to Apr 2024